What Changed
Price Move History
- Daily moves over 5%
- 83 124 sessions, October 6, 2025 to October 8, 2026
- Largest daily move
- +100% close of July 6, 2026
- 1-year change
- -45.9% closing prices, October 6, 2025 to October 8, 2026
- 1-month change
- -13.3% closing prices, September 8, 2026 to October 8, 2026
Company Description
PROTECT PHARMS (OTC: PRTT) is classified in the integrated freight & logistics industry within the Industrials sector and carries a market capitalization of $7.5M.
PRTT has declined 45.9% over the past year. The last closing price was $0.1300.
This page collects what Stock Titan holds for PRTT, including price data, latest news, and short interest trends.
Stock Performance
PROTECT PHARMS (PRTT) closed at $0.1300 on October 8, 2026. Over the past 12 months, the price has lost 45.9%.
PRTT Metrics & Rankings
Price returns through October 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
PROTECT PHARMS has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, management. View all PRTT news →
SEC Filings
Short Interest History
Short interest in PROTECT PHARMS (PRTT) currently stands at 12.6 thousand shares, down 22.7% from the previous reporting period, representing 0.0% of the shares outstanding. Since October 2025, short interest has increased by 83626.7%.
Days to Cover History
Days to cover for PROTECT PHARMS (PRTT) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
PRTT Company Profile & Sector Positioning
PROTECT PHARMS (PRTT) operates in the Integrated Freight & Logistics industry within the broader Industrials sector and is listed on the OTC.
Investors comparing PRTT often look at related companies in the same sector, including TITANIUM TRANSPRTATION GP (TTNMF), PARCELPAL LOGISTICS INC (PTNYF), FBR LTD (FBRKF), PACIFIC GREEN TECHS (PGTK), and CYBERLUX CORP (CYBL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PRTT's relative position within its industry.